Core 2 - Rapid Multipathogen Detection For POCT and Natioal Disaster Readiness

核心2.确定协作探索性项目的计划 探索性POCT技术项目的时间表。酷睿2将生产新的 符合危急-紧急灾难核心3主题的病原体检测技术 关心。核心2共包括六个试探性项目：a)每两年四个项目 在期限上，b)一个为期18个月的项目，c)一个为期一年的项目。第一轮核心 2个奖项将在第一年早些时候公布。第一个项目将于2008年4月1日开始。 在第一年年中开始的四个核心2项目中的第一个项目将继续两个 好几年了。接下来的两个月将以每12个月一次的速度分阶段实施。第四场比赛将从 从第四年开始，到第五年结束。为期18个月的项目将于年中开始。 三年，以及为期一年的项目，在第五年开始时。与Core 1临床并行 将对测试、核心1和2原型设备、试剂和质量控制材料进行评估 为了稳健性，指定的PoC系统逐渐为野外试验做好了准备。 我们还将为成功的健壮原型征求PoC连接建议书 第四年和第五年较短的特殊探索期(18个月、12个月)。这些 互联互通项目可能包括早期成功的探索性项目的延续 使原型能够完全现场用于POC的医学解释和跟踪 救援和灾难期间的检测结果。

Core 2. Plan for Identifying Collaborative Exploratory Projects Timeline for Exploratory POCT Technology Projects. Core 2 will produce new pathogen detection technologies consistent with the Core 3 theme of critical-emergencvdisaster care. Core 2 includes a total of six exploratory projects: a) four projects each two years in duration, b) one eighteen-month project, and c) one one-year project. The first round of Core 2 awards will be announced early in year one. The first project will start 1 April 2008. The first of four Core 2 projects, which begins in the middle of year one, will continue two years. The next two will be phased in at a rate of one per twelve months. The fourth will begin at the start of year four and end at the end of year five. The eighteen-month project will begin midyear three, and the one-year project, at the beginning of year five. In parallel with Core 1 clinical testing, Core 1 and 2 prototype devices, reagents, and quality control materials will be evaluated for robustness, and a designated line of POC systems progressively readied for field trails. We also will solicit POC connectivity proposals for successful robust prototypes for the shorter special exploratory periods (18 months, 12 months) in years four and five. These connectivity projects may include continuations of earlier successful exploratory projects in order to make the prototypes fully field enabled for medical interpretation and tracking of POC test results during rescue and disaster.